FEB 24, 2017 12:25 PM PST

B Cells Empower Vaccines to be Effective Long-Term

WRITTEN BY: Kara Marker

An unexpected interaction between regulatory immune cells and antibody-producing plasma cells surprised scientists, but this communication seems beneficial for the immune system’s ability to protect the body from infection.

The protozoan Toxoplasma gondii, tissue cyst in brain. Source: Science Life

From the University of Pennsylvania, researchers visualized the response of plasma cells to a parasite called Toxoplasma gondii, which causes a disease called toxoplasmosis that is especially dangerous to pregnant women and individuals with compromised immune systems. High-resolution microscopy technology provided them an inside view into live cells, where they saw plasma cells participating in some strange behavior.

Precursor B cells give rise to plasma cells, which are responsible for producing antibodies and conferring protection against infection. During exposure to T. gondii, researchers saw plasma cells from bone marrow tissue in mice disappear only to return later when the parasitic infection was under control.

“We don’t know whether these cells leave the bone marrow or die there during infection, but, either way, they are gone,” said co-leader of the study, Arielle Glatman Zaretzky. “And that set up a great system to understand what kinds of cellular interactions normally create the hospitable environment and allow the plasma cells to remain there.”

They later saw that regulatory T cells (T regs) levels declined in a similar fashion to the plasma cells in response to parasitic infection, which is when they first realized the collaborative connection between T regs and plasma cells.

This connection was thought to be that T regs were making the bone marrow “comfy” for the plasma cells, ensuring the environment was appropriately tuned for plasma cell flourishing. Without T regs, plasma cells cease to exist.

“This interaction was completely unanticipated,” said senior author Christopher A. Hunter. “If we can understand what controls these long-lived plasma cells, the maybe we can augment that interaction, making more plasma cells to, for example, enhance vaccine efficiency. Or if you want to limit autoimmunity or cancer, maybe there is an opportunity to disrupt this niche to mitigate some of these conditions.”

Both T regs and plasma cells also interact with dendritic cells, which scientists believe also promotes plasma cell survival. The present study was published in the journal Cell Reports.

Sources: Nature Reviews Immunology, Centers for Disease Control and Prevention, University of Pennsylvania

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 31, 2020
Health & Medicine
MAR 31, 2020
20 Facts About the Placenta - A Lifeline Between a Mother and Her Baby
The placenta is the lifeline that connects the mother and her baby. It is a multi-functiona organ that is responsible fo ...
APR 21, 2020
APR 21, 2020
A Nasal Vaccine Against Tau Tangles
  One of the hallmarks of Alzheimer’s disease (AD) is the accumulation of “tau tangles”. Tau is a ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
MAY 18, 2020
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
MAY 16, 2020
MAY 16, 2020
Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection
Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that av ...
Loading Comments...